Department of Medicine
Faculty Profiles by Division

Department of Medicine

Faculty Profiles

[Return To Index page]
photo Craig D. Seaman, MD, MS

Hematology/Oncology

Assistant Professor of Medicine, Division of Hematology/Oncology

Associate Director, Hemophilia Center of Western Pennsylvania

Email: seamanc@upmc.edu

Phone: 412-209-7308

Contact
Office: Hemophilia Center of Western Pennsylvania
201 N. Craig St.
Pittsburgh, PA 15213
 
Phone: 412-209-7308
Fax: 412-209-7281
E-mail: seamanc@upmc.edu
Administrative Assistant:
Devera Hoblak
Address: Hemophilia Center of WPA
201 N. Craig St.
Pittsburgh, PA 15213
Email: dhoblak@vitalant.org
Phone: 412-209-7354
Fax: 412-208-7281
Education and Training
Education
BS, West Virginia University, 2004
MD, Marshall University, 2008
MS, University of Pittsburgh, 2015
Training
Internal Medicine Residency, University of Pittsburgh Medical Center, 2011
Hematology/Oncology Fellowship, University of Pittsburgh Medical Center, 2014
Research Interest
My primary research focus is on the role of aging and aging-related conditions in hereditary bleeding disorders, specifically von Willebrand disease and hemophilia. My current research interests focus on the effects of aging on von Willebrand factor levels and bleeding phenotype in von Willebrand disease.
Clinical Interest
My clinical interests involve non-cancerous blood disorders, specifically disorders of hemostasis and thrombosis, including von Willebrand disease and hemophilia. At the Hemophilia Center of Western Pennsylvania, my clinic consists of patients with bleeding or clotting disorders. In addition, I have a general benign hematology clinic at Falk Medical Building.
Publications
Selected Publications:
Seaman C. Efficacy of adjusted weight-based dosing of DDAVP in type 1 von Willebrand disease. Blood Coagulation and Fibrinolysis. 2023; 34: 462-464.
Seaman C. Von Willebrand disease in older patients: A retrospective electronic health record review. Clinical Applied Thrombosis/Hemostasis. 2022; 28: 1-6.
Seaman C, Yabes J, Lalama C, Ragni MV. Factor VIII concentrate dosing with alternative descriptors of body weight in overweight and obesity: A randomized, controlled, open-label, crossover trial. Haemophilia. 2021; 27: 351-357.
Seaman C, Bertolet M, Zhang J, Ragni MV. Quality of peri-procedural care in patients with von Willebrand disease. Haemophilia. 2021; 27: 830-836.
Seaman C, Ragni MV. The effects of age on von Willebrand factor and bleeding symptoms in von Willebrand disease. Thrombosis Haemostasis. 2020; 120: 1159-1169.
Seaman C, Ragni MV. Perioperative management of von Willebrand disease: An institutional experience. Haemophilia. 2019; 25: 199-203.
Seaman C, Ragni MV. The association of aging with von Willebrand factor levels and bleeding risk in type 1 von Willebrand disease. Clinical and Applied Thrombosis/Hemostasis. 2018; 24: 434-438.
Apostolova MH, Seaman C, Comer DM, Yabes YG, Ragni MV. Prevalence and risk factors associated with hypertension in von Willebrand disease. Clinical and Applied Thrombosis/Hemostasis. 2018; 24: 93-99.
Seaman C, George KM, Ragni M, Folsom AR. Association of von Willebrand factor deficiency with prevalent cardiovascular disease and asymptomatic carotid atherosclerosis: The Atherosclerosis Risk in Communities Study. Thrombosis Research. 2016; 236-238.
Seaman C, Yabes J, Comer D, Ragni MV. Does deficiency of von Willebrand factor protect against cardiovascular disease? Analysis of a national discharge. Journal of Thrombosis and Haemostasis. 2015; 13: 1999-2013.
Sponsored Research/Activities
Title: THE VON WILLEBRAND DISEASE AGING AND BLEEDING CORRELATION (VWD ABC) STUDY
Role: Principal Investigator
Funding Agency: National Heart, Lung, & Blood Institute
Grant Number: K23 HL148762
Start Year: 2020
End Year: 2025
Notable Achievements
Member, Early Career Reviewer, Center for Scientific Review, NIH, 2021-present
Ad Hoc Reviewer, Hemostasis, Thrombosis, Bloods Cells and Transfusion Study Section, NIH, 2022
Member, HONORS Study Section, American Society of Hematology, 2022-present
Member, Ambassador Program, American Society of Hematology, 2022-2023
Member, K Awardee to R Advancement Training Leadership Council (KARAT), University of Pittsburgh, 2021-present
Member, Executive Committee, Mid-Atlantic Region III Federally Funded Hemophilia Treatment Center, 2020-present
National Institutes of Health loan repayment plan award, 2019-2023
Member, Presentation and Publication Committee, Community Counts: CDC Public Health Surveillance Project for Bleeding Disorders, 2018-2021
Member, Expert Contributor, British Medicine Journal: Best Practice, Von Willebrand disease, 2023-present